Cargando…
Explore the effect of LLY‐283 on the ototoxicity of auditory cells caused by cisplatin: A bioinformatic analysis based on RNA‐seq
BACKGROUND: Cisplatin is a commonly used chemotherapeutic drug in clinics, and long‐term application will lead to hearing impairment. LLY‐283, an inhibitor of PRMT5, has not been reported in deafness. Our study aimed to explore the mechanism of LLY‐283 in hearing impairment. MATERIALS AND METHODS: F...
Autores principales: | Zhao, Bin, Zhang, Dongdong, Sun, Yixin, Lei, Min, Zeng, Peiji, Wang, Yue, Hong, Yongjun, Jiao, Yanchao, Cai, Chengfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842247/ https://www.ncbi.nlm.nih.gov/pubmed/34997776 http://dx.doi.org/10.1002/jcla.24176 |
Ejemplares similares
-
Deciphering the potential ability of RG108 in cisplatin-induced HEI-OC1 ototoxicity: a research based on RNA-seq and molecular biology experiment
por: Zhang, Dongdong, et al.
Publicado: (2023) -
Using Oracle lli
por: Crum, Jim
Publicado: (2002) -
Web‐based transcriptome analysis determines a sixteen‐gene signature and associated drugs on hearing loss patients: A bioinformatics approach
por: Lei, Min, et al.
Publicado: (2021) -
Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021) -
Cartas de amor a Lli Brik, 1917-1930
por: Mayakovsky, Vladimir, 1893-1930
Publicado: (1976)